A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
The purpose of the study is to compare the efficacy of bimekizumab versus risankizumab after 16 weeks of treatment in study participants with active psoriatic arthritis (PsA).
Epistemonikos ID: 89e7317965b117bd7140b1f9bf125a9986f58aa2
First added on: Apr 17, 2025